Fig. 2From: A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocolOverview of blood sample acquisition and biorepository. Created with BioRender.comBack to article page